Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairment-Reference-Cited by-同舟云学术

Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairment

Published:2018-03 Issue:2 Volume:12 Page:133-142
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Okubo Tomomi,Atsukawa Masanori,Tsubota Akihito,Toyoda Hidenori,Shimada Noritomo,Abe Hiroshi,Kato Keizo,Hayama Korenobu,Arai Taeang,Nakagawa-Iwashita Ai,Itokawa Norio,Kondo Chisa,Kawamoto Chiaki,Iio Etsuko,Tanaka Yasuhito,Kumada Takashi,Iwakiri Katsuhiko

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

http://link.springer.com/article/10.1007/s12072-018-9859-9/fulltext.html

Reference29 articles.

1. Kumada H, Suzuki Y, Ikeda K, et al. Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection. Hepatology. 2014;59(6):2083–2091

2. Mizokami M, Dvory-Sobol H, Izumi N, et al. Resistance analyses of Japanese hepatitis c-infected patients receiving sofosbuvir or ledipasvir/sofosbuvir containing regimens in phase 3 studies. J Viral Hepat 2016;23(10):780–788

3. Kumada H, Chayama K, Rodrigues L Jr, et al. Randomized phase 3 trial of ombitasvir/paritaprevir/ritonavir for hepatitis C virus genotype 1b-infected Japanese patients with or without cirrhosis. Hepatology. 2015;62(4):1037–1046

4. Kumada H, Suzuki Y, Karino Y, et al. The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III study. J Gastroenterol 2017;52(4):520–533

5. Afdhal N, Reddy KR, Nelson DR, et al. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. N Engl J Med 2014;370(16):1483–1493

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors Associated with Large Renal Function Decline in Patients with Chronic Hepatitis C Successfully Treated with Direct-Acting Antiviral Therapy;Diagnostics;2023-01-27

2. Real-world effectiveness of genotype-specific and pangenotypic direct-acting antivirals in HCV-infected patients with renal failure;Clinical and Experimental Hepatology;2023

3. Clinical profile and response to treatment in chronic hepatitis C and renal disease: A prospective study from North India;Journal of Integrative Medicine and Public Health;2023

4. Changes in renal function in patients with chronic hepatitis C treated with sofosbuvir‐velpatasvir;Advances in Digestive Medicine;2022-09-29

5. Association of hepatitis C virus infection status and genotype with kidney disease risk: A population-based cross-sectional study;PLOS ONE;2022-07-08